Spyre Therapeutics (SYRE) Current Leases (2019 - 2023)
Spyre Therapeutics posted quarterly Current Leases of $4.3 million for Q2 2023, up 807.97% year-on-year from $477000.0 in Q2 2022, and up 612.34% on a QoQ basis from $608000.0 in Q1 2023.
Spyre Therapeutics (SYRE) has 5 years of Current Leases data on file, last reported at $4.3 million in Q2 2023.
- For the quarter ending Q2 2023, Current Leases rose 807.97% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2023 stood at $4.3 million (up 807.97% YoY), and the FY2022 full-year result was $625000.0, up 43.35% from the prior year.
- Current Leases for Q2 2023 stood at $4.3 million, up from $608000.0 in the prior quarter.
- Across five years, Current Leases topped out at $4.3 million in Q2 2023 and bottomed at $228000.0 in Q2 2020.
- The 5-year median for Current Leases is $381500.0 (2019), against an average of $618277.8.
- The widest annual swing landed in 2020, when Current Leases plunged 30.49%; it then surged 807.97% in 2023.
- A 5-year view of Current Leases shows it stood at $351000.0 in 2019, then dropped by 9.12% to $319000.0 in 2020, then jumped by 36.68% to $436000.0 in 2021, then surged by 43.35% to $625000.0 in 2022, then jumped by 592.96% to $4.3 million in 2023.
- The last three Current Leases figures came in at $4.3 million (Q2 2023), $608000.0 (Q1 2023), and $625000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 608,000.00 |
| Dec 31, 2022 | 625,000.00 |
| Sep 30, 2022 | 587,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Mar 31, 2022 | 457,000.00 |
| Dec 31, 2021 | 436,000.00 |
| Sep 30, 2021 | 415,000.00 |
| Jun 30, 2021 | 412,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Dec 31, 2020 | 319,000.00 |
| Sep 30, 2020 | 341,000.00 |
| Jun 30, 2020 | 228,000.00 |
| Mar 31, 2020 | 293,000.00 |
| Dec 31, 2019 | 351,000.00 |
| Sep 30, 2019 | 289,000.00 |
| Jun 30, 2019 | 328,000.00 |
| Mar 31, 2019 | 317,000.00 |